Antibiotic Treatment for Cellulitis in a 17-Year-Old
For a 17-year-old with cellulitis, cephalexin should be administered at a dosage of 500 mg orally every 6 hours (2 g daily) for 5-10 days, with treatment individualized based on clinical response. 1
Recommended First-Line Treatment
Cephalexin (First-Line Option)
- Dosage: 500 mg orally every 6 hours (2 g daily)
- Alternative dosing: 500 mg every 12 hours for uncomplicated cellulitis 1
- Duration: 5-10 days (5 days may be sufficient for uncomplicated cases) 2
- Rationale: Targets typical Gram-positive pathogens including beta-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus, which are the predominant causes of non-purulent cellulitis 3
Dicloxacillin (Alternative Option)
- Dosage: 250 mg orally every 6 hours (1 g daily) 4
- Duration: 5-10 days, continuing at least 48 hours after the patient becomes afebrile and asymptomatic 4
- Administration: Best absorbed when taken on an empty stomach (1 hour before or 2 hours after meals) with at least 120 mL of water 4
Treatment Considerations
Assessment for MRSA Risk
- For standard non-purulent cellulitis, MRSA coverage is generally not necessary 3
- If purulent drainage is present or MRSA is suspected:
- Consider adding TMP-SMX to cephalexin OR
- Switch to clindamycin 600 mg orally three times daily 2
Severity Assessment
- Mild to moderate cellulitis: Oral therapy as outlined above
- Severe cellulitis: Consider hospitalization and parenteral antibiotics if:
- Rapid progression
- Systemic symptoms (fever, tachycardia)
- Immunocompromised state
- Failed outpatient therapy
Duration of Treatment
- Standard duration: 5-10 days 2
- Continue until:
- Recent evidence suggests 5 days may be as effective as 10 days for uncomplicated cases 2
Monitoring and Follow-up
- Evaluate response within 48-72 hours
- Treatment failure signs include:
- Fever
- Increase in erythema (>25%), swelling, or tenderness after 3-4 days
- No decrease in symptoms after 3-4 days 5
Clinical Pearls and Pitfalls
Pitfall: Unnecessarily adding MRSA coverage for non-purulent cellulitis. Studies show that cephalexin alone is generally sufficient for typical non-purulent cellulitis 6, 5.
Pitfall: Inadequate dosing. For a 17-year-old (adult-sized patient), use adult dosing rather than pediatric weight-based dosing to ensure adequate coverage 1.
Pearl: Consider obtaining cultures from any purulent drainage to guide therapy if initial empiric treatment fails 2.
Pearl: Elevating the affected area can help reduce edema and speed resolution of symptoms 2.